Efficacy of galcanezumab in patients with migraine who did not benefit from commonly prescribed preventive treatments

BACKGROUND: Galcanezumab is a calcitonin gene-related peptide (CGRP) monoclonal antibody (mAb) indicated for the preventive treatment of migraine. While galcanezumab has demonstrated efficacy in patients who did not respond to prior preventive medications in general, its efficacy in patients who did...

Full description

Saved in:
Bibliographic Details
Published in:BMC Neurol
Main Authors: Kuruppu, Dulanji K., Tobin, Joshua, Dong, Yan, Aurora, Sheena K., Yunes-Medina, Laura, Green, A. Laine
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8063415/
https://ncbi.nlm.nih.gov/pubmed/33892641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-021-02196-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items